TCT 2019: Five-Year PARTNER 2A Results Support TAVR In Most Intermediate Risk Patients

 
• By Reed Miller
  
Aerial cityscape view of San Francisco, California, USA - Image
• Source: shutterstock.com

More from Clinical Trials

More from R&D